Venture Funding Deals: Gotham Raises $54m To Advance Epitranscriptomics

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced September and October 2018.

Venture Funding Reg column image

More from Deals

More from Business